Skip to main content
Arcus Biosciences, Inc. (RCUS)
NYSE: RCUS · Real-Time Price · USD
8.28
-0.25 (-2.93%)
At close: May 9, 2025, 4:00 PM
8.88
+0.60 (7.25%)
After-hours: May 9, 2025, 7:33 PM EDT

Arcus Biosciences Revenue by Segment
Period Ending Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020
License and Devlopment Services
226.00M 207.00M 198.00M 80.00M 84.00M 85.74M 83.44M 74.37M
License and Devlopment Services Growth
169.05% 141.42% 137.31% 7.56% -78.64% -76.80% -76.36% -78.44%
Other Collaboration
37.00M 40.00M 39.00M 37.00M 36.00M 35.84M 35.91M 37.97M
Other Collaboration Growth
2.78% 11.61% 8.62% -2.56% -8.85% -8.38% -6.77% 0.16%
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.